Blood News and Research

RSS

Fecal transplant and fiber supplementation can benefit patients with obesity-related metabolic syndrome

A transplant of healthy gut microbes followed by fiber supplements benefits patients with severe obesity and metabolic syndrome, according to University of Alberta clinical trial findings published today in Nature Medicine.

6 Jul 2021

Simple blood tests may help prevent inaccuracy in the diagnosis of severe malaria

Using simple blood tests could help researchers identify children who have been misidentified as having severe malaria, according to a study published today in eLife.

6 Jul 2021

22 blood plasma lipids found to be associated with lower symptom improvement in schizophrenia

Researchers from Skoltech and the Mental Health Research Center have found 22 lipids in the blood plasma of people with schizophrenia that were associated with lower symptom improvement over time during treatment.

6 Jul 2021

Researchers unravel mechanisms that produce individualized metabolism in leukemia

A research collaboration based in Kumamoto University (Japan) has shown that lysine-specific demethylase 1 (LSD1), an enzyme involved in gene expression, produces individualized metabolism depending on the type of acute myeloid leukemia cells.

6 Jul 2021

Metabolomics lab analysis reveals large nutritional differences between near-meat and meat

Plant-based meat substitutes taste and chew remarkably similar to real beef, and the 13 items listed on their nutrition labels - vitamins, fats and protein -- make them seem essentially equivalent.

6 Jul 2021

Eight new research projects to explore COVID-19 variants of concern in Canada

Eight new research projects are getting underway in Canada to investigate COVID-19 variants of concern (VOCs) and variants of interest (VOIs).

6 Jul 2021

Chemotherapy destabilizes gut microbiome in cancer patients

New research in BMC Cancer has shown myelosuppressive chemotherapy destabilizes gut microbiome in patients with solid organ cancers.

6 Jul 2021

Angiotensin II type 1 receptor-targeting autoantibodies may increase COVID-19 severity

A team of US-based scientists recently demonstrated that pro-thrombotic autoantibodies that target angiotensin II type 1 receptor (AT1R) may be associated with endothelial complications observed in coronavirus disease 2019 (COVID-19), a novel disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

6 Jul 2021

Anti-rheumatic drug combinations could reduce the risk of heart attack and strokes

New research evaluating the drugs commonly used by rheumatoid arthritis patients suggests two combinations could reduce the risk of heart attack and strokes.

6 Jul 2021

Gene-edited cellular therapeutics can successfully treat cardiovascular and pulmonary diseases

Scientists at UC San Francisco have shown that gene-edited cellular therapeutics can be used to successfully treat cardiovascular and pulmonary diseases, potentially paving the way for developing less expensive cellular therapies to treat diseases for which there are currently few viable options.

6 Jul 2021

New blood test for improved frontotemporal dementia diagnostics

A new study by researchers at the University of Eastern Finland shows for the first time that blood-based measurement of glial fibrillary acidic protein (GFAP) enables distinguishing patients with frontotemporal dementia from those with primary psychiatric disorders or healthy individuals.

6 Jul 2021

Serum testosterone status recovery an accurate predictor of survival in male COVID-19 patients

In a study available on the medRxiv* the preprint server, researchers from Spain showed that testosterone trajectories are very accurate individual predictors of survival in male patients with COVID-19. To better understand the relationship between testosterone levels and disease severity, they studied a group of male and female COVID-19 patients assessing their serum and blood biomarkers in association with outcome of disease.

6 Jul 2021

Castration of male sheep slows DNA aging

Most of us are familiar with the fact that women live longer than men. But fellas, if we told you there was one thing that could be done to increase your lifespan, would you do it?

6 Jul 2021

School-based mindfulness improves sleep quality in children

A new study exploring the benefits of mindfulness showed that children slept 74 minutes more on average after starting basic mindfulness exercises at school.

6 Jul 2021

Two chemoattenuated PfSPZ malaria vaccines provide strong and lasting protection

A team of researchers recently optimized regimens for CVac, wherein aseptic, purified, cryopreserved, and infectious PfSPZ were inoculated and mixed with PYR and CQ.

5 Jul 2021

Nanomaterials' physiochemical properties influence their ability to penetrate the blood brain barrier

Nanomaterials found in consumer and health-care products can pass from the bloodstream to the brain side of a blood-brain barrier model with varying ease depending on their shape - creating potential neurological impacts that could be both positive and negative, a new study reveals.

5 Jul 2021

Dimeric IgA antibodies help identify recent SARS-CoV-2 infection

A fascinating new study, released as a preprint on the medRxiv* server, adds a highly appealing tool to the armory of detection techniques for the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Its validation could allow the early and accurate detection of recent or active infection, which is valuable in tracing contacts and preventing forward transmission of the virus.

5 Jul 2021

Viennese scientists awarded grant to find ways for improving and personalizing dialysis care

Patients with malfunctioning kidneys often need dialysis to rid their blood of unwanted molecules and excess water.

5 Jul 2021

Bone marrow–derived fibrin clot may become a treatment for meniscus injuries

While this isn't the fountain of youth, scientists may have improved healing in our joints - even in areas that become weaker as we grow older.

5 Jul 2021

Scientists identify natural SARS-CoV-2 super immunity against 23 variants

The antibodies are capable of neutralizing a wide range of SARS-CoV-2 variants even at sub-nanomolar concentrations. In addition, the combinations of these antibodies reduce the risk of generating escape mutants in vitro. The study is published in the journal Science.

5 Jul 2021

Blood News and Research

Fecal transplant and fiber supplementation can benefit patients with obesity-related metabolic syndrome

Simple blood tests may help prevent inaccuracy in the diagnosis of severe malaria

22 blood plasma lipids found to be associated with lower symptom improvement in schizophrenia

Researchers unravel mechanisms that produce individualized metabolism in leukemia

Metabolomics lab analysis reveals large nutritional differences between near-meat and meat

Eight new research projects to explore COVID-19 variants of concern in Canada

Chemotherapy destabilizes gut microbiome in cancer patients

Angiotensin II type 1 receptor-targeting autoantibodies may increase COVID-19 severity

Anti-rheumatic drug combinations could reduce the risk of heart attack and strokes

Gene-edited cellular therapeutics can successfully treat cardiovascular and pulmonary diseases

New blood test for improved frontotemporal dementia diagnostics

Serum testosterone status recovery an accurate predictor of survival in male COVID-19 patients

Castration of male sheep slows DNA aging

School-based mindfulness improves sleep quality in children

Two chemoattenuated PfSPZ malaria vaccines provide strong and lasting protection

Nanomaterials' physiochemical properties influence their ability to penetrate the blood brain barrier

Dimeric IgA antibodies help identify recent SARS-CoV-2 infection

Viennese scientists awarded grant to find ways for improving and personalizing dialysis care

Bone marrow–derived fibrin clot may become a treatment for meniscus injuries

Scientists identify natural SARS-CoV-2 super immunity against 23 variants

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News